MissionIR Articles
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) to Release Q1 Fiscal Year 2020 Financial Results and Host Earnings Call
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) on Tuesday announced its plans to report first quarter fiscal year 2020 financial results before markets open on Tuesday, August 27, 2019. According to the update, Canopy Rivers will…
-
MissionIRNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Develops Technology to Provide Rapid-Onset of Cannabinoid Effects
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, has developed a unique, proprietary nano-emulsification technology that is anticipated to deliver an initial onset of effects…
-
Pressure BioSciences Inc. (PBIO) Enters Contract Services Agreement with World-Renowned Biotherapeutics Firm
PBIO expects to achieve a significant revenue increase in 2019 and beyond through the expansion of its proprietary BaroFold platform into the estimated $44 billion global bioprocess technology market Over 200 therapeutic proteins and peptides…
-
MissionIRNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Recent Achievements as Part of Overall Expansion Strategy
Clinical-stage gene therapy company Genprex (NASDAQ: GNPX) this morning announced its recent achievements as part of the company’s overall strategy to expand its clinical development programs and bring its lead drug candidate, Oncoprex(TM) immunogene therapy,…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) Subsidiary Receives Health Canada Cannabis R&D License
Biotechnology company and drug delivery platform innovator Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) today announced that Health Canada has issued cannabis Research and Development (“R&D”) license LIC-7NONT76UNW-2019 to its subsidiary, Lexaria CanPharm ULC. According…
-
MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Releases Q2 2019 Financial Results, Provides Shareholder Update
INmune Bio, Inc. (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced its financial results for the second quarter ended June 30, 2019…
-
MissionIRNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) CLR Roasters Awarded Supply Partnership with Hialeah, Florida’s Municipal Services
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced that its CLR Roasters was awarded a supply partnership with the city of Hialeah’s municipal services. According…
-
MissionIRNewsBreaks – Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) Announces Receipt of Conditional Approval to Graduate to the Toronto Stock Exchange
Canopy Rivers Inc. (TSX.V: RIV) (OTC: CNPOF) this morning announced its receipt of conditional approval from the Toronto Stock Exchange (“TSX”) to graduate from the TSX Venture Exchange (the “TSXV”) and list its class A…
-
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Named Among Greenest Cannabis Firms, Renews Health Canada Licenses
TGOD received a 100 percent organic rating from Toronto-based Corporate Knights magazine The company successfully renewed its Health Canada licenses authorizing the cultivation, processing and sale of cannabis from its Ancaster, Ontario, facility The cannabis…
-
MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) Adds Pet Chews to HEMP FX Line, Brand Featured in Forbes Article
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced that it is adding Pet Chews to its HEMP FX(TM) line of hemp infused products. Designed for…
-
MissionIRNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Announces Issuance, Sale of Additional Shares Per Exercise of Underwriter’s Over-Allotment Option in IPO
Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a producer, developer and operator of popular augmented reality interactive entertainment games and toys in China, today announced the issuance and sale of an additional 141,114 ordinary shares,…
-
MissionIRNewsBreaks – Organigram Holdings Inc. (TSX.V: OGI) (NASDAQ: OGI) Receives Conditional Approval to Uplist to the TSX
Organigram Holdings (TSX.V: OGI) (NASDAQ: OGI), the parent company of Organigram Inc., a leading licensed producer of cannabis, on Thursday announced that it has received conditional approval from the Toronto Stock Exchange (“TSX”) to uplist…
-
MissionIRNewsBreaks – Canopy Rivers Inc.’s (TSX.V: RIV) (OTC: CNPOF) Portfolio Company Receives 12th AGLC Cannabis Retail License
Canopy Rivers (TSX.V: RIV) (OTC: CNPOF) this morning announced that its portfolio company, YSS Corp. (TSX.V: YSS) (WKN: A2PMAX), has received its 12th cannabis retail license from the Alberta Gaming, Liquor and Cannabis Commission (“AGLC”).…
-
MissionIRNewsBreaks – INmune Bio, Inc. (NASDAQ: INMB) Names Biotechnology Executive as New Board Member
INmune Bio (NASDAQ: INMB), an immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, today announced that Edgardo “Ed” Baracchini, Ph.D., has joined its board of directors. Per…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Completes Initial R&D Program with the National Research Council of Canada
Biotechnology company and drug delivery platform innovator Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) today announced successful completion of its Master Collaborative Research Agreement (“the R&D Program”) with the National Research Council of Canada (“NRC”). The…
-
Earth Science Tech Inc. (ETST) Offers Innovative, Well-Branded CBD Products
Earth Science Tech operates through diverse subsidiaries in the CBD space The company offers a wide range of CBD products, as well as its MSN-2 medical device ETST has varied distribution agreements in place to…
-
INmune Bio Inc. (NASDAQ: INMB) Planning Phase II Trial of INB03 as Part of Combination Immunotherapy for Cancer Patients
INmune Bio is currently attending the Cambridge Healthcare Institute’s 7th Annual Immuno-Oncology Summit in Boston Co-founder and CEO Dr. RJ Tesi is presenting positive preliminary data on INB03, which is being developed as part of…
-
MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Submits Application for NASDAQ Listing
Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF) this morning announced that it has applied to list its common shares on the NASDAQ under the symbol ‘TGOD’. The listing…
-
MissionIRNewsBreaks – Youngevity International Inc. (NASDAQ: YGYI) to Host Conference Call to Discuss Q2 2019 Financial Results, Provide Corporate Update
Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments, this morning announced that it will host a conference call at 1:00 PM Eastern Daylight Time on Wednesday, August 14,…
-
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Reviews Expansion of Client Base, Noting Unprecedented Number of License Agreements
Lexaria’s patented DehydraTECH technology improves taste, achieves higher absorption rates and promotes fast onset of bioactive compounds, including nicotine and cannabinoids Nine corporate licensees have signed a total of 11 definitive contracts to use DehydraTECH technology…
Search Articles
Latest Articles
- BluSky AI Inc. (BSAI): Democratizing AI Through Modular Infrastructure and a New Neocloud That Scales from Startup to Enterprise
- MissionIRNewsBreaks – Solowin Holdings (NASDAQ: SWIN) Integrates Chainlink Data Services Into Tokenized Money Market Fund
- Brera Holdings PLC (NASDAQ: BREA) Gains Outperform Rating from PartnerCap Securities, Price Target Set at $11.50
- MissionIRNewsBreaks – Lantern Pharma Inc. (NASDAQ: LTRN) Advances Predictive Power in Cancer Drug Development
- MissionIRNewsBreaks – Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Positioned to Drive RapidSX(TM) Toward Commercial Launch